Table 1.

Study Patients’ Profiles

	Group 1 (n = 27)	Group 2 (n = 48)	P value
Sex ratio (F/M)	0.50	0.92	0.22
Mean age, years (std deviation)	66 (9.8)	61.25 (10.9)	0.06
Site
Colon	9 (71%)	32 (66%)	0.74
Rectum	8 (29%)	16 (33%)
LN metastases (Duke’s >B in colonic specimen)	81.5%	82%	0.73
No. of liver tumors (mean) (std deviation)	1.19 (0.4)	2.52 (1.9)	0.0001
Max tumor diameter (largest) (std deviation)	3.53 cm (2.84)	3.9 cm (1.84)	0.49
Extrahepatic disease (no. of patients)	7	9	0.56
Prior liver resection	4	6	1
Mean MSKCC risk score (range)	1.82 (0–4)	2.48 (2–5)	0.003

Group 1, immediate hepatic resection; Group 2, hepatic resection following neoadjuvant chemotherapy

LN = lymph node